Posted by: Audrey Erbes | October 21, 2012

Keep Up to Date on the Changing Life Science Ecosystem

As noted earlier venture capital funding of life science industry startups is down but that doesn’t mean that business development has ceased to exist. As seen in this coming week’s list of events, many programs and events are dealing with the discovery and development of new drugs and tools; and alternative means of funding; improvements in marketing products to react to challenges of greater concern based on new ecosystem. California life science entrepreneurs and company professionals recognize that it has never been easy to develop a business but that hasn’t stopped them in the past and won’t in the future. New science is flush with new inventions and breakthroughs—that isn’t the issue—it’s the need for new business models for firms in our industry and sharper opportunity assessment to ensure that the new outstanding science sees fruition in excellent products that provide better outcomes. New models of funding are being tested to provide startups with power to develop.

You might be interested in attending my upcoming very affordable “Life Science Business Development” course at the downtown center of UC Berkeley Extension, Dec. 6-7, 2012. I’ll be covering the impact of the new ecosystem for bioscience business development—discussing trends and outlook for the coming years. See the details at See the flyer for your information with outline and listing of guest speakers.

There was a major shot across the bow of pharmaceutical pricing this past week. At Memorial Sloan-Kettering Cancer Center they took step to deny a new cancer drug on their formulary due to doubling in price vs. an existing therapy without any differential in therapeutic impact. As noted the typical patient needing the therapy lives on a Social Security monthly check stipend less than the 20% copay of over $2,000 per therapy month required by Medicare. Payors are becoming more aware of the need to curb prices of new drugs, especially, biologics that often don’t provide an efficacy rate greater than 15%. Check out the RealEndpoint blog which includes outstanding research and commentary on the changing pricing and reimbursement environment. The blog is complimentary at

Highlights for this week’s events:

  • BioCentury TV Today, See new program Webcast Starting Sunday, Oct. 21, 2012, Available anytime starting at 9:00 a.m. EDT; Topic: “Clinical Revolution:Rethinking Drug Studies;” Speaker: Dr. Janet Woodcock, Director of FDA’s Center for Drug Evaluation and Research (CDER).; Dr. Garry Neil, Acting CEO of TransCelerate BioPharma and David Wholley, Director of the Biomarkers Consortium for the Foundation for the National Institutes of Health.
  • CACO, Monday, Oct. 22, 2012; Topic: Minisymposium: Case Studies for the Discovery of New Molecular Entities: From Concept and Optimization to the Clinic; Speakers: Steve Richards, Exelixis;Andrei Konradi, Elan;Julio Medina, Amgen;Alex Muci, Cytokinetics; John Jacobsen, Theravance
  • 3rd Presidential Debate, Monday Evening, Oct. 22, 2012; Topic: Foreign policy; Participants: President Barack Obama and Governor Mitt Romney; Moderator: Bob Schieffer (Host of Face the Nation on CBS)
  • Bio2Device Group, Tuesday Morning, Oct. 23, 2012; Topic: “Angel View on Investing;” Speaker: Lee Rauch, Health Tech Capital
  • BioScience Forum, Wednesday Evening, Oct. 24, 2012; Topic: “Polymer Conjugation Technology in Small Molecule Drug Design and Discovery;” Speaker: Stephen Doberstein, Ph.D., Senior Vice President and Chief Scientific Officer,Nektar Therapeutics, Inc.
  • Golden Gate Polymer Forum, Wednesday Evening, Oct. 24, 2012; Event: October Dinner Lecture; Topic: “Nanofiber Macromolecular Constructs: Applications in Medicine and Linkages to Biology;” Speaker: Prof. Gary E. Wnek, Department of Macromolecular Science and Engineering,  Case Western Reserve University
  • Women in Bio, Thursday Evening, October 25, 2012; Topic: “Wine and Wisdom with Congresswoman;” Speakers: Jackie Speier and BioTech Nation’s Moira Gunn
  • Pharmaceutical Executive and Model N, Thursday Midday, Oct. 25, 2012; Topic: “The Path to Agile Brand Management;” Presenters: David Stasior, M.D. Vice President and Chief Evangelist, Analytics Model N; Jason Jones, Senior Director Sales, Operations and Insights, Covidien; Moderator: Ben Comer, Senior Editor, Pharmaceutical Executive
  • Health Technology Forum, Thursday Evening, Oct. 25, 2012; Topic: “Advanced Communications Technologies in Healthcare: A 360 Degree Conversation;” Speaker: Douglas TraunerUCSF Mission Bay, Friday, Oct. 26, 2012
  • UCSF Mission Bay, Friday, Oct. 26, 2012; Event Topic: “HealthTech Conference 2012: Building a Business in the New HealthTech Ecosystem!!!” What are the unmet needs of the providers: Amir Dan Rubin, President & CEO, Stanford Hospital & Clinics; Tomi Ryba, President & CEO, El Camino Hospital; Mark R. Laret, CEO, UCSF Medical Center; Rich Roth, VP Strategic Innovation, Dignity Health; “Enabling technologies disrupting healthcare delivery,”Jack J. Young, Managing Director, Qualcomm Life Fund, Qualcomm Ventures; Aimee Jungman, VP Health & Wellness Innovation, Frog Design; Kenneth R. Pelletier, PhD, MD(hc), Clinical Professor of Medicine, UCSF and University of Arizona; “How to build a HealthTech business,”Robert Zollars, Chairman & CEO, Vocera Communications; Ashley Dombowski, PhD, CBO, 23andMe; Alan Portela, CEO, Airstrip Technologies; “What are Investors/Acquirers are looking for?”Stephen Bloch, MD, General Partner, Canaan Partners; Thomas McKinley, General Partner, Cardinal Partners; Brian Ascher, Partner, Venrock; Tom Rodgers, Corporate Development and Ventures, Cambia Health Solutions

Download Audrey’s Picks with all the details about events through the end of the year and my latest Jobs That Crossed My Desk. Just right click on the highlighted titles.



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s


%d bloggers like this: